Thyroid Association News Today

Hypothyroidism in pregnancy was associated with lower parity, higher age, higher BMI, and nonsmoking status despite poor discriminative ability.

Following the release of new data on a core offering, Research Capital analyst Andre Uddin remains upbeat about the prospects of Sernova.

Proof-of-concept data supports the clinical evaluation of the Cell Pouch System as a potential treatment for post-operative hypothyroidism...

Sernova Corp. announced new preclinical data for its novel cell therapy platform, the Cell Pouch System, as a potential treatment for post-operative hypothyroidism at the 2023 American Thyroid...

HAYWARD - Pulse Biosciences, Inc. , a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology for the treatment of atrial fibrillation, today...

Company also introduces research-use-only Afirma Genomic Resource for Intelligent Discovery platform for additional insights into thyroid nodules and cancer ...

Thyroid autoimmunity among women with infertility was not associated with embryo quality or cumulative live birth rate after IVF or intracytoplasmic sperm injection, researchers reported in Thyroid.“Associations between thyroid autoimmunity and pregnancy outcomes have long been investigated, and several meta-analyses have shown increased risks of pregnancy loss and preterm birth in women

The past 5–10 years have brought in a new era in the care of patients with thyroid cancer, with the introduction of transformative diagnostic and management options. Several international ultrasound-based thyroid nodule risk stratification systems have been developed with the goal of reducing unnecessary biopsies. Less invasive alternatives to surgery for low-risk thyroid cancer, such as active surveillance and minimally invasive interventions, are being explored. New systemic therapies are no...

Find information about available non-chemotherapy treatments for thyroid carcinoma, including total thyroidectomy, radiodine treatment, and ablation.

The lack of supporting evidence in the management of pediatric differentiated thyroid carcinoma means cultural divergences and expert opinion drive the differences between US and European guidelines.